CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged cord blood transplant shows promise for faster recovery in blood cancer patients
Disease control CompletedThis study tested a special stem cell product called NiCord, made by growing cord blood cells in a lab to increase their number. It was compared to standard cord blood transplants in 125 people with blood cancers like leukemia and lymphoma. The goal was to see if NiCord could hel…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
One donor, two transplants: new hope for patients with blood cancer and kidney failure
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched family donor for 10 people with both a serious blood disorder and chronic kidney disease. The goal was to treat both conditions with one donor, potentially reducing the need for lifelong anti-…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 18, 2026 12:01 UTC